These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28934266)
1. Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it? Yang Z; van Busschbach J; Timman R; Janssen MF; Luo N PLoS One; 2017; 12(9):e0184883. PubMed ID: 28934266 [TBL] [Abstract][Full Text] [Related]
2. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study. Ludwig K; von der Schulenburg JG; Greiner W Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389 [TBL] [Abstract][Full Text] [Related]
3. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L. Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340 [TBL] [Abstract][Full Text] [Related]
4. Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States: A Study in the Brazilian Population. Andrade MV; Noronha K; Kind P; Reis Cde B; de Carvalho LR Med Decis Making; 2016 Feb; 36(2):242-52. PubMed ID: 26289747 [TBL] [Abstract][Full Text] [Related]
5. Exploring non-iterative time trade-off methods for valuation of EQ-5D-5L health states. Yang Z; Rand K; Stolk E; Busschbach J; Luo N Eur J Health Econ; 2024 Sep; 25(7):1087-1094. PubMed ID: 38104294 [TBL] [Abstract][Full Text] [Related]
6. Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study. Al Sayah F; Johnson JA; Ohinmaa A; Xie F; Bansback N; Qual Life Res; 2017 Jun; 26(6):1483-1492. PubMed ID: 28124280 [TBL] [Abstract][Full Text] [Related]
7. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899 [TBL] [Abstract][Full Text] [Related]
8. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663 [TBL] [Abstract][Full Text] [Related]
9. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments. Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626 [TBL] [Abstract][Full Text] [Related]
10. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off. Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810 [TBL] [Abstract][Full Text] [Related]
11. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945 [TBL] [Abstract][Full Text] [Related]
12. Inconsistencies in TTO and VAS values for EQ-5D health states. Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171 [TBL] [Abstract][Full Text] [Related]
13. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267 [TBL] [Abstract][Full Text] [Related]
14. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values? Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R Value Health; 2016; 19(2):210-7. PubMed ID: 27021755 [TBL] [Abstract][Full Text] [Related]
15. United States Valuation of EQ-5D-5L Health States Using an International Protocol. Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935 [TBL] [Abstract][Full Text] [Related]
16. Censoring Time Trade-off Values at 0 Versus at -1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data? Yang Z; Rand K; Luo N Value Health; 2023 May; 26(5):685-693. PubMed ID: 36375679 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off Data. Wong ELY; Shah K; Cheung AWL; Wong AYK; Visser M; Stolk E Value Health; 2018 Jun; 21(6):732-741. PubMed ID: 29909879 [TBL] [Abstract][Full Text] [Related]
18. Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese. Wang P; Li MH; Liu GG; Thumboo J; Luo N Eur J Health Econ; 2015 Nov; 16(8):857-63. PubMed ID: 25260384 [TBL] [Abstract][Full Text] [Related]
19. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks. Che M; Pullenayegum E Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604 [TBL] [Abstract][Full Text] [Related]
20. How different are composite and traditional TTO valuations of severe EQ-5D-5L states? Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA Qual Life Res; 2016 Aug; 25(8):2101-8. PubMed ID: 26875190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]